{"id":"https://openalex.org/W1990366181","doi":"https://doi.org/10.1097/00001813-199406000-00011","title":"Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment","display_name":"Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment","alternate_titles":[],"publication_year":1994,"publication_date":"1994-06-01","ids":{"openalex":"https://openalex.org/W1990366181","doi":"https://doi.org/10.1097/00001813-199406000-00011","mag":"1990366181","pmid":"https://pubmed.ncbi.nlm.nih.gov/7919458"},"language":"en","primary_location":{"id":"doi:10.1097/00001813-199406000-00011","doi":"https://doi.org/10.1097/00001813-199406000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199406000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1990366181"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044052235","display_name":"Paola Principe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Paola Principe","raw_affiliation_strings":["Institut Henri Beaufour, Les Ulis, France","Fax: (+33) 1 69 82 92 30","Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Henri Beaufour, Les Ulis, France","institution_ids":[]},{"raw_affiliation_string":"Fax: (+33) 1 69 82 92 30","institution_ids":[]},{"raw_affiliation_string":"Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111934725","display_name":"A M Faussat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133078","display_name":"H\u00f4tel-Dieu de Paris","ror":"https://ror.org/03jmjy508","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210124464","https://openalex.org/I4210133078"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Anne Marie Faussat-Suberville","raw_affiliation_strings":["Laboratoire de Cin\u00e9tique et de Cultures Cellulaires, H\u00f4tel Dieu, 75004 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Cin\u00e9tique et de Cultures Cellulaires, H\u00f4tel Dieu, 75004 Paris, France","institution_ids":["https://openalex.org/I4210133078"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053791312","display_name":"H\u00e9l\u00e8ne M. Coulomb","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H\u00e9l\u00e8ne Coulomb","raw_affiliation_strings":["Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15; Fax: (+33) 1 69 82 92 30","Fax: (+33) 1 69 82 92 30","Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15; Fax: (+33) 1 69 82 92 30","institution_ids":[]},{"raw_affiliation_string":"Fax: (+33) 1 69 82 92 30","institution_ids":[]},{"raw_affiliation_string":"Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112233576","display_name":"Jean\u2010Pierre Marie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133078","display_name":"H\u00f4tel-Dieu de Paris","ror":"https://ror.org/03jmjy508","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210124464","https://openalex.org/I4210133078"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jean-Pierre Marie","raw_affiliation_strings":["Laboratoire de Cin\u00e9tique et de Cultures Cellulaires, H\u00f4tel Dieu, 75004 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Cin\u00e9tique et de Cultures Cellulaires, H\u00f4tel Dieu, 75004 Paris, France","institution_ids":["https://openalex.org/I4210133078"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109990436","display_name":"Pierre G. Braquet","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Pierre Braquet","raw_affiliation_strings":["Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15; Fax: (+33) 1 69 82 92 30","Fax: (+33) 1 69 82 92 30","Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15; Fax: (+33) 1 69 82 92 30","institution_ids":[]},{"raw_affiliation_string":"Fax: (+33) 1 69 82 92 30","institution_ids":[]},{"raw_affiliation_string":"Institut Henri Beaufour, 1 avenue des Tropiques, 91952 Les Ulis, France. Tel: (+33) 1 69 07 91 15","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7356,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.72185215,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"3","first_page":"329","last_page":"335"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8535000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.8535000085830688,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10407","display_name":"Lipid Membrane Structure and Behavior","score":0.12470000237226486,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.005100000184029341,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ether-phospholipids","display_name":"ether phospholipids","score":0.9940000176429749},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6690000295639038},{"id":"https://openalex.org/keywords/multidrug-resistance","display_name":"multidrug resistance","score":0.8820000290870667},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.996999979019165},{"id":"https://openalex.org/keywords/edelfosine","display_name":"edelfosine","score":0.8169999718666077},{"id":"https://openalex.org/keywords/daunorubicin","display_name":"daunorubicin","score":0.7509999871253967},{"id":"https://openalex.org/keywords/verapamil","display_name":"verapamil","score":0.722000002861023},{"id":"https://openalex.org/keywords/cyclosporine","display_name":"cyclosporine","score":0.996999979019165},{"id":"https://openalex.org/keywords/leukemia-cell-lines","display_name":"leukemia cell lines","score":0.8050000071525574},{"id":"https://openalex.org/keywords/k562-cells","display_name":"K562 cells","score":0.7680000066757202},{"id":"https://openalex.org/keywords/hl60","display_name":"HL60","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cem","display_name":"CEM","score":0.9509999752044678},{"id":"https://openalex.org/keywords/anti-neoplastic-drugs","display_name":"anti-neoplastic drugs","score":0.7390000224113464}],"concepts":[{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.6609276533126831},{"id":"https://openalex.org/C2778918659","wikidata":"https://www.wikidata.org/wiki/Q186915","display_name":"Phospholipid","level":3,"score":0.5588748455047607},{"id":"https://openalex.org/C2780407432","wikidata":"https://www.wikidata.org/wiki/Q103230","display_name":"Ether","level":2,"score":0.44248029589653015},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.4319917857646942},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3970474600791931},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.3834128975868225},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2519950270652771},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17101508378982544},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1432933807373047},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.1411132514476776},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.054136455059051514},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.05335226655006409},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.05009666085243225}],"mesh":[{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D003630","descriptor_name":"Daunorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004354","descriptor_name":"Drug Screening Assays, Antitumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D007951","descriptor_name":"Leukemia, Myeloid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010742","descriptor_name":"Phospholipid Ethers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D014700","descriptor_name":"Verapamil","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D015458","descriptor_name":"Leukemia, T-Cell","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D015458","descriptor_name":"Leukemia, T-Cell","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016572","descriptor_name":"Cyclosporine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D020168","descriptor_name":"ATP Binding Cassette Transporter, Subfamily B, Member 1","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00001813-199406000-00011","doi":"https://doi.org/10.1097/00001813-199406000-00011","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00001813-199406000-00011","pdf_url":null,"source":{"id":"https://openalex.org/S158028025","display_name":"Anti-Cancer Drugs","issn_l":"0959-4973","issn":["0959-4973","1473-5741"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-Cancer Drugs","raw_type":"journal-article"},{"id":"pmid:7919458","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7919458","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Anti-cancer drugs","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2062644898","https://openalex.org/W2411873519","https://openalex.org/W1619310950","https://openalex.org/W2414766849","https://openalex.org/W1986966481","https://openalex.org/W1971779359","https://openalex.org/W2010057549","https://openalex.org/W2024688228","https://openalex.org/W2319619421","https://openalex.org/W2048118253"],"abstract_inverted_index":{"Ether":[0],"phospholipids":[1],"are":[2,173],"new":[3,39,170],"anti-neoplastic":[4],"drugs":[5,172],"that":[6,154,168],"have":[7,22,84],"been":[8,85,112,139],"found":[9,86,113,140],"active":[10],"against":[11],"a":[12,38],"variety":[13],"of":[14,27,96,107,181],"tumor":[15,183],"cell":[16,46,62,119,184],"lines,":[17,47],"including":[18],"drug-resistant":[19,67],"sublines.":[20],"We":[21],"characterized":[23],"the":[24,89,94,97,108,130,143,155,163,177,182],"antiproliferative":[25],"activity":[26],"three":[28,44],"ether":[29,123,131,156],"phospholipids,":[30],"i.e.":[31,48,69],"ET-18-OCH3":[32],"(Edelfosine),":[33],"BM":[34],"41.440":[35],"(limofosine)":[36],"and":[37,59,64,77,117,148,167],"aza-derivative":[40],"(BN":[41],"52205),":[42],"on":[43,134],"leukemic":[45],"K562":[49],"(chronic":[50],"myeloid":[51],"leukemia,":[52],"blast":[53],"crisis),":[54],"HL60":[55],"(promyelocytic":[56],"acute":[57],"leukemia)":[58],"CEM":[60],"(T":[61],"leukemia),":[63],"their":[65],"respective":[66],"sublines,":[68],"K562-ADR":[70],"(adryamicin":[71],"resistant),":[72],"HL60-DNR":[73],"[daunorubicin":[74],"(DNR)":[75],"resistant]":[76],"CEM-VLB":[78],"(vinblastin":[79],"resistant).":[80],"These":[81,151],"resistant":[82,118,128],"sublines":[83],"to":[87,175],"express":[88],"multidrug-resistant":[90],"phenotype,":[91],"revealed":[92],"by":[93,146],"presence":[95],"P-glycoprotein":[98],"(PgP)":[99],"using":[100],"different":[101,122],"monoclonal":[102],"antibodies.":[103],"Increased":[104],"cellular":[105],"accumulation":[106,136],"fluorescent":[109],"anthracycline":[110],"has":[111,137],"in":[114],"both":[115],"sensitive":[116],"lines":[120],"after":[121,141],"phospholipid":[124,132,157],"treatment":[125],"times.":[126],"In":[127],"cells,":[129],"effect":[133],"DNR":[135],"also":[138],"blocking":[142],"PgP":[144],"function":[145],"verapamil":[147],"cyclosporin":[149],"A.":[150],"results":[152],"confirm":[153],"action":[158],"is":[159],"closely":[160],"linked":[161],"with":[162],"membrane":[164],"biochemical":[165],"composition":[166],"these":[169],"anti-tumor":[171],"able":[174],"change":[176],"dynamic":[178],"structural":[179],"organization":[180],"membrane.":[185]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1990366181","counts_by_year":[],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
